BrainsWay is engaged in the R&D and sales of a medical system for non-invasive treatment of common brain disorders. It is based on a proprietary technology, Deep TMS, which can reach significant depth and breadth of the brain and produce broad stimulation of targeted brain areas. In the U.S., the Company’s device has been FDA cleared for the treatment of MDD since 2013 and is now FDA cleared for the treatment of OCD. The systems have CE clearance for the treatment of various brain disorders
Copyright 2018, a2z, Inc. All rights reserved.